| 体内研究: |
Adenosine N1-oxide (口服,135 mg/kg,三次) 可降低 LPS 诱导的 BALB/c 小鼠内毒素休克的致死率。 |
| 参考文献: |
1. Kohno K, et al. Anti-inflammatory effects of adenosine N1-oxide. J Inflamm (Lond). 2015;12(1):2. Published 2015 Jan 20. 2. Ohashi E, et al. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation. Biol Pharm Bull. 2019;42(6):968-976. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.531 ml |
17.653 ml |
35.306 ml |
| 5 mM |
0.706 ml |
3.531 ml |
7.061 ml |
| 10 mM |
0.353 ml |
1.765 ml |
3.531 ml |
| 50 mM |
0.071 ml |
0.353 ml |
0.706 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |